Chairman Yen has more than 40 years of experience in the pharmaceutical industry and is deeply involved in the distribution and business development of pharmaceutical markets in Taiwan and Asia. Based on the business philosophy of 以人為本、由心出發, he is committed to leading the company to become the world's most innovative international biotechnology company. He is currently the board member of several biotechnology companies and a co-founder of Pharmosa Limited (a predecessor of Pharmosa Biopharm Inc.)
Jerry Wang received his M.S. degree in Department of Pharmacology from National Cheng Kung University and B.S. degree in School of Pharmacy from Kaohsiung Medical University. He also has a professional pharmacist license. Has more than 25 years of experience in the pharmaceutical industry. He and Dr. Yan co-founded Anxo Pharmaceutical Co. Ltd, established a strong R&D team, and successfully produced more than 160 drug permit licenses from TFDA. He maintained the integrity of the upper, middle and lower streams of the pharmaceutical industry supply chain, covering raw materials, pharmaceutical production and sales channels to create a complete pharmaceutical supply chain of group companies. Director Wang is concurrently the Chairman and President of Anxo Pharmaceutical Co., Ltd.; Chairman and President of Taxo Pharmaceutical Co., Ltd.; Chairman and President of Aupa biopharm Co., Ltd.; as well as board member of several biotechnology companies and a co-founder of Pharmosa Limited (a predecessor of Pharmosa Biopharm Inc.).
Lin-chiuan Yan, Ph.DDirector
Dr. Yan obtained his Ph.D. in Chemical Engineering from the University of Michigan at Ann Arbor and received his M.S. and B.S. degree in Chemical Engineering from National Cheng Kung University. He has co-founded several pharmaceutical companies with Jerry Wang Pharmacists and has more than 20 years of business performance experience. Has complete international market development experience with international pharmaceutical companies in China, Japan and Europe and the United States, and experience with expanding sales markets throughout Asia. Leading the Group in the development of its various superior business strategies has enabled each company to continue to grow in the pharmaceutical industry, and to implement institutionalized management to push group companies to Taiwan’s capital markets. Dr. Yan is concurrently the Director and CEO of Anxo Pharmaceutical Co., Ltd.; Director and CEO of Taxo Pharmaceutical Co., Ltd.; Director and CEO of Aupa Diopharm Co., Ltd., as well as Chairman and board member of several biotechnology companies and a co-founder of Pharmosa Limited (a predecessor of Pharmosa Biopharm Inc.)
Pei Kan Ph.D.Director
Dr. Kan graduated from National Tsinghua University in Taiwan and completed post-doctoral research at Tsukuba University in Japan. He served as Associate Director of the Taiwan Liposomal Company, a Researcher at the Biomedical Engineering Center of the Industrial Technology Research Institute, and a Researcher at Tsukuba University in Japan. He has worked in the pharmaceutical industry for more than 20 years, focused on pharmaceutical formulation technology and product development, published over 50 papers and more than 10 patents related to drug delivery, some of which have been used in clinical products. In addition, he has led the development of several new formulation-based drug projects and completed filing and listing of IND, BioIND, and ANDA products in Taiwan, China, the United States, Japan, and Europe. He is now the President of Pharmosa.